Exact Mass: 362.0920954
Exact Mass Matches: 362.0920954
Found 147 metabolites which its exact mass value is equals to given mass value 362.0920954,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6-dimethoxy-3,4-dihydro-2H-1-benzopyran-4-one
Piretanide
D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors C - Cardiovascular system > C03 - Diuretics > C03C - High-ceiling diuretics > C03CA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators
3',6'-Dihydroxy-4,5-diaminospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one
Pentazirinocyclodiphosphathiazene
7,8-Di-Me ether-3-(3,4-Dihydroxybenzyl)-5,6,7,8-tetrahydroxy-4-chromanone
depside atranorin|Homodiploschistesinsaeure-methylester
Secosterigmatocystin
D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Methyl 18-Bromo-(17Z)-octadeca-17-ene-5,7,15-triynoate
2-caffeoyloxy-3-hydroxy-3-(3,4-dihydroxyphenyl)propyl alcohol
3-(3-Hydroxy-4-methoxybenzyl)-3,5,6-trihydroxy-7-methoxychroman-4-one
4,5-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3H-furo[2,3,4-kl]pyrrolo[4,3,2-fg][3]benzazocine-3,6(8H)-dionem|calanthumindole
Methyl 18-Bromo-(9Z,15Z,17E)-octadeca-9,15,17-triene-5,7-diynoate
O1-(4-phenoxy-phenyl)-beta-D-glucopyranuronic acid|O1-(4-Phenoxy-phenyl)-beta-D-glucopyranuronsaeure
DAF-2
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents
3,8-dihydroxy-1-methoxy-4-(1,3,4-trihydroxybutan-2-yl)xanthen-9-one
methyl 2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate
methyl 2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate
Piretanide
D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors C - Cardiovascular system > C03 - Diuretics > C03C - High-ceiling diuretics > C03CA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators
methyl 2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate [IIN-based: Match]
methyl 2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate [IIN-based on: CCMSLIB00000848992]
FR140423
C18H16F2N2O2S (362.09004999999996)
CONFIDENCE standard compound; INTERNAL_ID 660; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8446; ORIGINAL_PRECURSOR_SCAN_NO 8442 CONFIDENCE standard compound; INTERNAL_ID 660; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8470; ORIGINAL_PRECURSOR_SCAN_NO 8469 CONFIDENCE standard compound; INTERNAL_ID 660; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8485; ORIGINAL_PRECURSOR_SCAN_NO 8483 CONFIDENCE standard compound; INTERNAL_ID 660; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8519; ORIGINAL_PRECURSOR_SCAN_NO 8516 CONFIDENCE standard compound; INTERNAL_ID 660; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8520; ORIGINAL_PRECURSOR_SCAN_NO 8517 CONFIDENCE standard compound; INTERNAL_ID 660; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8527; ORIGINAL_PRECURSOR_SCAN_NO 8525
Methyl 18-bromo-9E,15E,17E-octadecatrien-5,7-diynoate
Methyl 18-bromo-9E,15E,17E-octadecatrien-5,7-diynoate
7-chloro-1-(2,3-dihydroxypropyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
C18H16ClFN2O3 (362.08334279999997)
Pyrano[2,3-c]pyrazole-5-carbonitrile,6-amino-4-(4-chlorophenyl)-1,4-dihydro-3-methyl-1-phenyl-
N4-(3-Chloro-4-fluorophenyl)-7-(2-methoxyethoxy)quinazoline-4,6-diamine
3-cyclopentyl-2-(3,4-dichlorophenyl)-N-pyridin-2-ylpropanamide
(R)-3-((6,7,8,9-TETRAHYDRO-5H-BENZO[7]ANNULEN-5-YL)THIO)-5-UREIDOISOTHIAZOLE-4-CARBOXAMIDE
1,5-diamino-4,8-dihydroxy(4-hydroxyphenyl)anthraquinone
4-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]-N,N-dimethylaniline,chloride
2-phenoxyethoxycarbonyloxy 2-phenoxyethyl carbonate
Trimethyl[1-(2,6-xylylcarbamoyl)ethyl]ammonium iodide
C14H23IN2O (362.08550579999996)
N-[3-cyano-4-[(4-methylphenyl)thio]phenyl]-4-fluorobenzamide
(Z)-5-[(5-hydroxy-7-methoxy-2-methyl-4-oxochromen-6-yl)methoxy]-3-methyl-5-oxopent-3-enoic acid
3-{5-[Amino(iminio)methyl]-6-chloro-1H-benzimidazol-2-YL}-1,1-biphenyl-2-olate
Methyl 2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate
5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6-dimethoxy-2,3-dihydrochromen-4-one
4-Acetyl-6-(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)-3,5-dihydroxy-6-methylcyclohexa-2,4-dien-1-one
7,8-Didemethyl-8-hydroxy-5-deazariboflavin(1-)
C16H16N3O7- (362.09882059999995)
5-Chloro-7-[3-pyridinyl-(2-pyridinylamino)methyl]-8-quinolinol
6-(1,3-benzodioxol-5-yl)-N-(2-thiazolylmethyl)-4-quinazolinamine
4-(6-Amino-5-cyano-3-methyl-1,4-dihydropyrano[2,3-c]pyrazol-4-yl)phenyl 2-furoate
4-chloro-N-[4-[3-(methylthio)anilino]-4-oxobutyl]benzamide
2-[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]-N-phenylacetamide
6-(3-Aminopropoxy)-4-(3-chloro-4-fluoroanilino)quinazolin-7-ol
4-[2,4-Dihydroxy-3-(hydroxymethyl)-6-methylbenzoyl]oxy-2-hydroxy-3,6-dimethylbenzoic acid
BPDBA
BPDBA is a selective and noncompetitive betaine/GABA transporter (BGT-1) inhibitor with IC50s of 20 μM and 35 μM against human BGT-1 and mouse GAT2, respectively[1].
BZAD-01
C16H12F6N2O (362.08537739999997)
BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit, with a Ki of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation[1].
(1s,2e,4e)-1-[(1r,6s)-4-[(acetyloxy)methyl]-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3-methyl-6-oxohexa-2,4-dien-1-yl acetate
(2s)-2-(2,6-dihydroxyphenyl)-5-hydroxy-6,7,8-trimethoxy-2,3-dihydro-1-benzopyran-4-one
methyl (9z,15z,17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate
6-[(2,4-dihydroxy-3,6-dimethylbenzoyloxy)methyl]-2,4-dihydroxy-3-methylbenzoic acid
3,8-dihydroxy-1-methoxy-4-[(2r,3s)-1,3,4-trihydroxybutan-2-yl]xanthen-9-one
(2r,4s)-5,10-dihydroxy-4,8-dimethoxy-2-(2-oxopropyl)-2h,3h,4h-naphtho[2,3-b]pyran-6,9-dione
5-(4-hydroxy-7-methoxy-6-methyl-2h-1,3-benzodioxol-5-yl)-7-methoxy-6-methyl-2h-1,3-benzodioxol-4-ol
3-[(3,4-dihydroxyphenyl)methyl]-5,6-dihydroxy-7,8-dimethoxy-2,3-dihydro-1-benzopyran-4-one
2,3-dihydroirigenin
{"Ingredient_id": "HBIN004022","Ingredient_name": "2,3-dihydroirigenin","Alias": "NA","Ingredient_formula": "C18H18O8","Ingredient_Smile": "COC1=CC(=CC(=C1OC)O)C2COC3=CC(=C(C(=C3C2=O)O)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15075","TCMID_id": "5646","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-caffeoyloxy-3-hydroxy-3-(3,4-dihydroxy-phenyl)propyl alcohol
{"Ingredient_id": "HBIN005434","Ingredient_name": "2-caffeoyloxy-3-hydroxy-3-(3,4-dihydroxy-phenyl)propyl alcohol","Alias": "NA","Ingredient_formula": "C18H18O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2915","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4- o -methylerythrostominone
{"Ingredient_id": "HBIN010783","Ingredient_name": "4- o -methylerythrostominone","Alias": "NA","Ingredient_formula": "C18H18O8","Ingredient_Smile": "CC(=O)CC1CC(C2=C(C3=C(C(=C2O1)O)C(=O)C(=CC3=O)OC)O)OC","Ingredient_weight": "362.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7986","PubChem_id": "101036749","DrugBank_id": "NA"}
{6-[1-(acetyloxy)-3-methyl-6-oxohexa-2,4-dien-1-yl]-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl}methyl acetate
(2r,4s)-6,9-dihydroxy-4,8-dimethoxy-2-(2-oxopropyl)-2h,3h,4h-naphtho[2,3-b]pyran-5,10-dione
(2s,3r)-2,5,7-trihydroxy-3-[(s)-hydroxy(4-hydroxyphenyl)methyl]-6-methoxy-8-methyl-2,3-dihydro-1-benzopyran-4-one
3,8-dihydroxy-1-methoxy-4-[(2s,3s)-1,3,4-trihydroxybutan-2-yl]xanthen-9-one
2,5,7-trihydroxy-3-[hydroxy(4-hydroxyphenyl)methyl]-6-methoxy-8-methyl-2,3-dihydro-1-benzopyran-4-one
(1r,2s,11r,13s)-1,6-dihydroxy-8-methoxy-13,15-dimethyl-3,12,14-trioxapentacyclo[11.4.1.0²,¹¹.0⁵,¹⁰.0¹¹,¹⁵]octadeca-5,7,9-triene-4,17-dione
15-chloro-6,14-dihydroxy-4,12-dipropyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
[(1r,2r,4r,5s,6r,7s)-5,6-bis(acetyloxy)-3,8-dioxatricyclo[5.1.0.0²,⁴]octan-4-yl]methyl benzoate
methyl (17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate
3,5,6-trihydroxy-3-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2h-1-benzopyran-4-one
methyl (17e)-18-bromooctadec-17-en-5,7,15-triynoate
methyl 3-hydroxy-2-[3-hydroxy-2-(methoxycarbonyl)-5-methylphenoxy]-5-methoxybenzoate
(2s,3r)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6-dimethoxy-2,3-dihydro-1-benzopyran-4-one
5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-2,3-dihydro-1-benzopyran-4-one
methyl 2-(4-hydroxy-3-{[2-hydroxy-5-(2-methoxy-2-oxoethyl)phenyl]sulfanyl}phenyl)acetate
C18H18O6S (362.08240480000006)